Kick-off meeting for the pharmacology studies and animal model development and related services for drug development IDIQ contract.

Ended Awarded

Contract number
75N95024F00001
Awardee
Awarding agency
Obligated
$1,000

Award facts

Opportunity
Contract value 100% obligated
$1,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Albuquerque, NM 87108, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75N95024F00001?

75N95024F00001 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on August 6, 2024.

How much is contract 75N95024F00001 worth?

The government has obligated $1,000 on 75N95024F00001.

Which agency awarded contract 75N95024F00001?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95024F00001 an order under another contract?

Yes. 75N95024F00001 is a delivery order under 75N95024D00027, an indefinite delivery contract.

Was contract 75N95024F00001 competed?

The extent of competition for 75N95024F00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login